Can You Switch IVIg to SCIg for Multifocal Motor Neuropathy?

For some people with Multifocal Motor Neuropathy (MMN) who are stable and responding well to Intravenous Immunoglobulin (IVIg), switching to Subcutaneous Immunoglobulin (SCIg) at home may be a practical option ^[1][2]. However, because MMN is rare, the evidence for SCIg comes mostly from small observational studies, and its use for MMN may be considered “off-label” depending on your country and the specific product ^[1]. While many patients in these studies maintained their muscle strength and function after switching, the transition requires careful medical supervision, specialized training, and a highly individualized dosing plan ^[3][4].

What is Immunoglobulin and How Does Dosing Differ?

Immunoglobulin (IgG) is a purified preparation of antibodies. In MMN, these antibodies help modulate your immune system to protect your nerves, with the goal of preserving muscle strength and function.

• IVIg (Intravenous): A larger, intermittent dose of medication is infused directly into a vein, typically every 3 to 4 weeks ^[5]. This usually requires a clinic visit, an IV line, and several hours.
• SCIg (Subcutaneous): The medication is infused into the subcutaneous tissue (the fatty layer just beneath the skin) using small needles ^[5][6]. Because this tissue can only hold a limited volume, the monthly dose is divided into smaller amounts ^[7]. SCIg is given more frequently—often weekly or twice a week—but each session is shorter ^[8][9].

Converting from IVIg to SCIg is not a simple math equation. Your specialist will calculate a product-specific schedule based on your previous IVIg dose, weight, and clinical response ^[3][10]. Never calculate, change, skip, or stop your doses yourself.

Comparing IVIg and SCIg

Steadier Blood Levels and the “Wearing-Off” Effect

Because IVIg delivers a large amount of antibodies all at once, your IgG levels spike and then gradually drop before your next dose ^[5]. For some patients, this drop causes a “wearing-off” effect, where weakness or fatigue returns right before the next infusion.

SCIg is absorbed gradually, providing a flatter, steadier level of IgG in your blood without dramatic peaks and troughs ^[5]. Some studies suggest this steadier state may reduce end-of-cycle symptom fluctuations for some patients ^[1][11]. However, it is not a guaranteed clinical benefit, and fatigue can have many other causes.

Pros and Cons of Switching

Potential Benefits (Pros)

• Independence and Flexibility: Home administration avoids frequent hospital trips, allowing treatments to fit around your life ^[6][9].
• No IV Access Needed: SCIg avoids the stress of repeated IV line placements in veins ^[6].
• Fewer Systemic Reactions: While systemic reactions (like severe headaches or nausea) can still happen, they are statistically less frequent with SCIg than with IVIg ^[1][6][12].

Potential Challenges (Cons)

• Hand Weakness and Dexterity: MMN specifically causes weakness in the hands and arms. Drawing up medication, handling vials, inserting needles, and operating a pump requires manual dexterity. If your hand function is impaired, you may need a caregiver or home nurse to assist you ^[4].
• Local Skin Reactions: Redness, swelling, and itching at the injection sites are very common ^[6][1]. These are often mild and can be managed by rotating sites, but you must monitor for signs of infection (such as spreading redness, heat, pus, or fever).
• Dose Adjustments: Finding the right dose takes time. In one real-world study of 13 MMN patients, about 40% required a dose increase after switching to maintain their strength ^[3]. If the replacement dose is too low, you may experience weakness ^[13].
• Logistics and Storage: You must manage medication refrigeration/storage, sharps disposal, pump maintenance, and insurance approvals.

Safety and Monitoring During the Transition

The transition period requires a strict monitoring plan. Your neuromuscular team will regularly assess your strength, grip, and physical function ^[13][3].

• New or Worsening Weakness: If you notice new weakness, do not adjust the dose yourself. Contact your care team promptly. Weakness could mean your dose needs adjustment, but it could also signal disease progression, an infusion problem, or another medical issue ^[13][3].
• Emergency Reactions: Although rare, severe allergic reactions (anaphylaxis) can occur with any immunoglobulin product ^[14]. You must have an emergency plan in place. If you develop hives, facial or throat swelling, trouble breathing, chest pain, or feel faint during an infusion, stop the pump immediately and call emergency services.